Atherogenic dyslipidemia and incident cardiovascular events in high-risk hypertension
Among SPRINT participants, AD was associated with a higher CVD risk. Early detection of AD in hypertensive patients, even without diabetes, may prompt greater therapeutic effort to reduce long-term CVD risk.
Authors
- Rishi Rikhi (ORCID: https://orcid.org/0000-0002-8013-4564)
- Michael D. Shapiro (ORCID: https://orcid.org/0000-0002-9071-3287)
- Shannon M. O’Connor (ORCID: https://orcid.org/0000-0002-7622-038X)
- Richard Kazibwe (ORCID: https://orcid.org/0000-0001-7085-3373)
- Joseph Yeboah (ORCID: https://orcid.org/0000-0001-6274-5882)
- Sneha Chebrolu (ORCID: https://orcid.org/0009-0001-3135-793X)
- Christopher L. Schaich (ORCID: https://orcid.org/0000-0002-5302-0828)
- Saeid Mirzai (ORCID: https://orcid.org/0000-0002-2579-4965)
- Parag Anilkumar Chevli (ORCID: https://orcid.org/0000-0002-4084-8175)
- Juliana H. Namutebi
- Jeshuah Jehopio
Institutions
- Atrium Health Wake Forest Baptist (US)
- Wake Forest University (US)
- Uganda Christian University (UG)
Publication Details
- Journal
- Progress in Cardiovascular Diseases
- Published
- 2025-05-18
- DOI
- https://doi.org/10.1016/j.pcad.2025.05.006
- Citations
- 5
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 10.03
Funders
- National Institutes of Health
- National Institute on Aging
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Disorders and Stroke